Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine

被引：32
|
作者：
Margetts, PJ
Churchill, DN
Alexopoulou, I
机构：
[1] McMaster Univ, Fac Hlth Sci, Div Nephrol, Hamilton, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2001年 / 32卷 / 02期
关键词：
interstitial nephritis; inflammatory bowel disease; mesalamine;
D O I：
10.1097/00004836-200102000-00019
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mesalamines are slow-release formulations: of 5-aminosalicylic acid (5-ASA) and are effective as primary treatment and maintenance therapy in inflammatory bowel disease. Interstitial nephritis is a recognized side effect. We report two cases of biopsy-confirmed interstitial nephritis in patients being treated with 5-ASA. Both had a trial of steroid therapy. One patient had partial recovery of renal function but the other patient was in chronic renal failure and likely was approaching the need for dialysis. Interstitial nephritis is an under-recognized complication of 5-ASA therapy. Early identification and withdrawal of this drug can lead to a partial or complete reversal of renal dysfunction.
引用
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
  • [21] Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease
    Jeffrey Tang
    Omar Sharif
    Chetan Pai
    Ann L. Silverman
    Digestive Diseases and Sciences, 2010, 55 : 1696 - 1703
  • [22] Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease
    Tang, Jeffrey
    Sharif, Omar
    Pai, Chetan
    Silverman, Ann L.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (06) : 1696 - 1703
  • [23] Epidemiology of Lupus Nephritis in Inflammatory Bowel Disease
    Tabanor, Joy-Ann
    Sharma, Prabin
    Aguilar, Rodrigo
    Mordon, Armenia
    Chedid, Alice
    Montero, Alex
    Shammash, Jonathan
    Siddiqui, Omer
    Li, Ping
    Nader, Mark
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 866 - 867
  • [24] Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease
    Suzuki, Kaoru
    Kakuta, Yoichi
    Naito, Takeo
    Takagawa, Tetsuya
    Hanai, Hiroyuki
    Araki, Hiroshi
    Sasaki, Yu
    Sakuraba, Hirotake
    Sasaki, Makoto
    Hisamatsu, Tadakazu
    Motoya, Satoshi
    Matsumoto, Takayuki
    Onodera, Motoyuki
    Ishiguro, Yoh
    Nakase, Hiroshi
    Andoh, Akira
    Hiraoka, Sakiko
    Shinozaki, Masaru
    Fujii, Toshimitsu
    Katsurada, Takehiko
    Kobayashi, Taku
    Fujiya, Mikihiro
    Otsuka, Takafumi
    Oshima, Naoki
    Suzuki, Yasuo
    Sato, Yuichirou
    Hokari, Ryota
    Noguchi, Mitsunori
    Ohta, Yuki
    Matsuura, Minoru
    Kawai, Yosuke
    Tokunaga, Katsushi
    Nagasaki, Masao
    Kudo, Hisaaki
    Minegishi, Naoko
    Okamoto, Daisuke
    Shimoyama, Yusuke
    Moroi, Rintaro
    Kuroha, Masatake
    Shiga, Hisashi
    Li, Dalin
    McGovern, Dermot P. B.
    Kinouchi, Yoshitaka
    Masamune, Atsushi
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 21 - 31
  • [25] Does Therapy with Oral Mesalamine Have An Effect On Renal Function in Patients with Inflammatory Bowel Disease?
    Blonski, Wojciech
    Osterman, Mark T.
    Mendizabal, Manuel
    Kotlyar, David
    Lin, Ming V.
    Lichtenstein, Gary R.
    GASTROENTEROLOGY, 2009, 136 (05) : A650 - A651
  • [26] Mesalazine-Induced Interstitial Nephritis in Children with Inflammatory Bowel Disease: Case Report and Literature Review
    Co, Maridine
    Linatoc, Julie Ann
    Gorospe, Emmanuel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S400 - S400
  • [27] VEDOLIZUMAB INDUCED INTERSTITIAL NEPHRITIS IN A CHILD WITH VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE: A CASE REPORT
    Svabova, Eva
    Vyhnanek, Radim
    Gonsorcikova, Lucie
    Dvorak, Pavel
    Zieg, Jakub
    PEDIATRIC NEPHROLOGY, 2023, 38 : S142 - S142
  • [28] Mesalamine in pediatric inflammatory bowel disease: A 10-year experience
    DAgata, ID
    Vanounou, T
    Seidman, E
    INFLAMMATORY BOWEL DISEASES, 1996, 2 (04) : 229 - 235
  • [29] Pyrexia in inflammatory bowel disease: Drug fever due to mesalamine as a cause
    Pathak, Parna
    Roy, Shankar
    Kumar, Rajinder
    Pahil, Sapna
    Suri, Vikas
    Sharma, Vishal
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2024,
  • [30] Articular Manifestations in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345